WitnessBio

买了点vktx查看全文

再见了，阿Q！你会留在我的记忆里的查看全文

我刚刚调整了雪球组合 $沙里淘金小药股(ZH1292713)$。查看全文

这个可能会有short squeeze,最近不少大佬买进查看全文

大名鼎鼎的薛定谔Schrodinger刚刚提交了上市申请，它主要用软件来帮助优化药厂传统的药物研发流程，现在和TAK, SNY, GILD等大药厂都有合作，值得期待。 $Schrodinger(SDGR)$查看全文

小药股的行情可以告一段落了吧？准备过圣诞节了查看全文

昨晚下了一尺的雪，上午铲雪机铲了两个多小时查看全文

$A股护盘(ZH1410418)$ @WitnessBio 成功为国护盘查看全文

$A股护盘(ZH1410418)$ @WitnessBio 这次的入点抓的不错，接近最低点了查看全文

$La Jolla制药(LJPC)$ 最近买了一点LJPC，KevinTang是大股东，Broadfin 最近也加仓了，60% short, 看样子反转了查看全文

转发查看全文

转发查看全文

$Arqule(ARQL)$ 黎明前的黑暗查看全文

$Affimed(AFMD)$ AFM13 + Keytruda in BV relapsed patients: the 46% CR rate fits nicely to an 88% best ORR with deepening responses to a 6 month progression free survival (pfs) rate of 77% at #ASH2018 now. From Dieter Hovekamp查看全文

$Arqule(ARQL)$ ARQ531 1/3 durable PR in highest 45 mg cohort (after ~45 wks dosing), strong dose response in C481S CLL with 5/8 pts with >20% tumor reduction. 4/20 Gr 3/4 TEAEs, fairly clean safety. Next dose 65 mg to be reported 1H and will continue dose escalation. Stron...查看全文

转发查看全文

$Viking Therapeutics, Inc.(VKTX)$ So to summarize $VKTX:-No safety signal, no thyroid axis issues, no lipid/LDL issues, no cardiac issues, no liver transferase issues-massive liver fat reduction with dose dependent activity-lipid panel improvements with >20% LDL-C reductio...查看全文

转发查看全文

转发查看全文

转发查看全文